Crossmark

Letter to the editor regarding “Safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation: experience from a German stroke center” by Mers et al.

Crossref DOI link: https://doi.org/10.1186/s42466-026-00458-8

Published Online: 2026-02-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zupan, Matija

Kermer, Pawel

Frol, Senta https://orcid.org/0000-0001-9494-160X
License Information

Text and Data Mining valid from 2026-02-09

Version of Record valid from 2026-02-09
More Information

Article History

Received: 9 December 2025

Accepted: 11 January 2026

First Online: 9 February 2026

Declarations

:

: The present research complies with the guidelines for human studies, and the research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki.

: Not applicable.

: MZ, PK, SF received speakers honoraria from AstraZeneca, Bayer, Boehringer Ingelheim.

Document is current

Any future updates will be listed below